Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma.
Arang N, Lubrano S, Ceribelli M, Rigiracciolo DC, Saddawi-Konefka R, Faraji F, Ramirez SI, Kim D, Tosto FA, Stevenson E, Zhou Y, Wang Z, Bogomolovas J, Molinolo AA, Swaney DL, Krogan NJ, Yang J, Coma S, Pachter JA, Aplin AE, Alessi DR, Thomas CJ, Gutkind JS. Arang N, et al. Among authors: rigiracciolo dc. Cell Rep Med. 2023 Nov 21;4(11):101244. doi: 10.1016/j.xcrm.2023.101244. Epub 2023 Oct 18. Cell Rep Med. 2023. PMID: 37858338 Free PMC article.
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway.
Cirillo F, Talia M, Santolla MF, Pellegrino M, Scordamaglia D, Spinelli A, De Rosis S, Giordano F, Muglia L, Zicarelli A, Di Dio M, Rigiracciolo DC, Miglietta AM, Filippelli G, De Francesco EM, Belfiore A, Lappano R, Maggiolini M. Cirillo F, et al. Among authors: rigiracciolo dc. Cell Death Discov. 2023 Sep 26;9(1):353. doi: 10.1038/s41420-023-01654-0. Cell Death Discov. 2023. PMID: 37749101 Free PMC article.
Publisher Correction: RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer.
Muoio MG, Pellegrino M, Rapicavoli V, Talia M, Scavo G, Sergi V, Vella V, Pettinato S, Galasso MG, Lappano R, Scordamaglia D, Cirillo F, Pulvirenti A, Rigiracciolo DC, Maggiolini M, Belfiore A, De Francesco EM. Muoio MG, et al. Among authors: rigiracciolo dc. Breast Cancer Res. 2023 Aug 10;25(1):94. doi: 10.1186/s13058-023-01689-2. Breast Cancer Res. 2023. PMID: 37563657 Free PMC article. No abstract available.
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer.
Muoio MG, Pellegrino M, Rapicavoli V, Talia M, Scavo G, Sergi V, Vella V, Pettinato S, Galasso MG, Lappano R, Scordamaglia D, Cirillo F, Pulvirenti A, Rigiracciolo DC, Maggiolini M, Belfiore A, De Francesco EM. Muoio MG, et al. Among authors: rigiracciolo dc. Breast Cancer Res. 2023 Jul 17;25(1):84. doi: 10.1186/s13058-023-01686-5. Breast Cancer Res. 2023. PMID: 37461077 Free PMC article.
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells.
Talia M, Cirillo F, Spinelli A, Zicarelli A, Scordamaglia D, Muglia L, De Rosis S, Rigiracciolo DC, Filippelli G, Perrotta ID, Davoli M, De Rosa R, Macirella R, Brunelli E, Miglietta AM, Nardo B, Tosoni D, Pece S, De Francesco EM, Belfiore A, Maggiolini M, Lappano R. Talia M, et al. Among authors: rigiracciolo dc. J Exp Clin Cancer Res. 2023 Jul 12;42(1):164. doi: 10.1186/s13046-023-02747-5. J Exp Clin Cancer Res. 2023. PMID: 37434266 Free PMC article.
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells.
Scordamaglia D, Cirillo F, Talia M, Santolla MF, Rigiracciolo DC, Muglia L, Zicarelli A, De Rosis S, Giordano F, Miglietta AM, De Francesco EM, Vella V, Belfiore A, Lappano R, Maggiolini M. Scordamaglia D, et al. Among authors: rigiracciolo dc. J Transl Med. 2022 Jun 7;20(1):263. doi: 10.1186/s12967-022-03463-y. J Transl Med. 2022. PMID: 35672854 Free PMC article.
Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC).
Rigiracciolo DC, Nohata N, Lappano R, Cirillo F, Talia M, Adame-Garcia SR, Arang N, Lubrano S, De Francesco EM, Belfiore A, Gutkind JS, Maggiolini M. Rigiracciolo DC, et al. J Exp Clin Cancer Res. 2022 Jun 3;41(1):193. doi: 10.1186/s13046-022-02396-0. J Exp Clin Cancer Res. 2022. PMID: 35655319 Free PMC article.
Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease.
Andreucci M, Rigiracciolo DC, Bracale UM, Ielapi N, Provenzano M, D'Iuorno D, Michael A, Mastroroberto P, Serraino GF, Maggiolini M, Serra R. Andreucci M, et al. Among authors: rigiracciolo dc. Heliyon. 2022 Jan 12;8(1):e08756. doi: 10.1016/j.heliyon.2022.e08756. eCollection 2022 Jan. Heliyon. 2022. PMID: 35059526 Free PMC article.
Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer-associated fibroblasts.
Cirillo F, Pellegrino M, Talia M, Perrotta ID, Rigiracciolo DC, Spinelli A, Scordamaglia D, Muglia L, Guzzi R, Miglietta AM, De Francesco EM, Belfiore A, Maggiolini M, Lappano R. Cirillo F, et al. Among authors: rigiracciolo dc. Clin Transl Med. 2021 Nov;11(11):e516. doi: 10.1002/ctm2.516. Clin Transl Med. 2021. PMID: 34841688 Free PMC article.
30 results